Stakeholder sentiment

What is stakeholder sentiment?

Stakeholder sentiment is the perceived emotional response, attitude or opinion of key audiences towards a product, company, topic, policy or clinical development. It is inferred from what stakeholders communicate and how they behave, or reported directly through research. Sentiment is commonly classified as positive, neutral or negative, although more detailed categories such as trust, concern, uncertainty or frustration may be useful.

Stakeholders can include healthcare professionals, payers, patients, carers, policy-makers, advocacy groups and other influencers. Sentiment is not the same as a confirmed belief or future action: it is an interpretation of available evidence and should be reported with its source, audience and context.

Why does stakeholder sentiment matter in Medical Affairs and market access?

For Medical Affairs, sentiment can reveal unmet information needs, scientific concerns, misunderstanding of evidence or changes in confidence. This helps teams choose appropriate engagement, refine scientific communication and identify issues that require further investigation rather than simply increasing message frequency.

For Market Access, it can indicate how payers and other decision-makers view clinical value, economic evidence, affordability, implementation or uncertainty. Tracking changes helps teams recognise reputational risks, emerging objections and positive momentum, and plan communication and engagement at the right time. It supports decision-making but does not by itself demonstrate trust or predict behaviour change.

How is stakeholder sentiment measured in practice?

Teams usually combine direct feedback with observed communications and behaviour. Common sources include surveys, interviews, advisory board feedback, field insights, published commentary, online communities and social media. A practical process is to:

• Define the stakeholder group, subject, geography, channel and period being assessed.
• Set a coding framework for positive, neutral and negative sentiment, with additional themes or emotions where needed.
• Collect relevant material and remove duplicates, irrelevant mentions, spam and content outside the agreed scope.
• Classify each response or mention manually, with software, or through a combination of both.
• Check ambiguous language, clinical context, sarcasm and mixed opinions through human review.
• Compare results by stakeholder segment, topic, source and time period rather than relying only on one overall score.
• Record the methodology and limitations so that later comparisons use a consistent basis.

Survey findings represent direct responses to specific questions. Digital sources provide unsolicited but often less representative views. Volume, reach and engagement should be reported separately from sentiment because a widely shared negative comment and many low-visibility positive comments do not have the same implications.

Can sentiment be compared across stakeholder groups and channels?

It can, but only when the differences in evidence are made clear. Payers, clinicians and patients may assess the same issue against different needs and may use different language. Similarly, advisory board discussion, field notes and public social posts are produced in different settings and should not be treated as equivalent samples.

Good reporting shows where each finding came from, how many relevant observations support it, whether contributors were identifiable, and whether the channel is likely to over-represent highly engaged voices. Trends are usually more informative when the scope and coding remain stable. A change in data source, platform access or classification method can look like a change in sentiment when stakeholder opinion has not changed.

Who should own stakeholder sentiment and how should teams act on it?

Ownership is often shared across Medical Affairs, market access, insights, communications and commercial teams, with governance reflecting the source and intended use. One team should maintain the definitions, coding rules and reporting cadence so that functions do not produce conflicting interpretations of the same audience.

Action should follow the underlying issue, not merely the label. Negative sentiment caused by uncertainty may require clearer evidence communication or new insight generation; frustration with service delivery may require an operational response. Positive sentiment may identify messages that are understood, but it should not be presented as proof of preference, advocacy or prescribing intent. Teams should also apply privacy, consent, pharmacovigilance and compliance processes appropriate to each source.

How does stakeholder sentiment differ from sentiment analysis and digital listening?

Stakeholder sentiment is the attitude or emotional response being assessed. Sentiment analysis is the method used to identify and classify that attitude in text or other communications. Digital listening is the broader collection and examination of online conversations, which may include sentiment alongside themes, audiences, reach and patterns of engagement.

The terms therefore sit at different levels: digital listening supplies a source of evidence, sentiment analysis provides an analytical technique, and stakeholder sentiment is the resulting insight about a defined audience. Surveys, interviews and advisory boards can also measure stakeholder sentiment without using digital listening.